504 results on '"Cantini, Fabrizio"'
Search Results
2. Duration of remission after halving of the etanercept dose in patients with ankylosing spondylitis : a randomized, prospective, long-term, follow-up study
3. Efficacy of infliximab in refractory Behçet's disease-associated and idiopathic posterior segment uveitis : a prospective, follow-up study of 50 patients
4. Sustained maintenance of clinical remission after adalimumab dose reduction in patients with early psoriatic arthritis: a long-term follow-up study
5. Booster dose of SARS-CoV-2 messenger RNA vaccines strengthens the specific immune response of patients with rheumatoid arthritis: A prospective multicenter longitudinal study
6. Epidemiology and Genetics
7. Classification Criteria
8. Efficacy and Safety of Filgotinib in Rheumatoid Arthritis Patients Aged over and under 65 Years (ENANTIA-65).
9. Alternative biomarkers of tuberculosis infection in patients with immune-mediated inflammatory diseases
10. Immune Therapy, or Antiviral Therapy, or Both for COVID-19: A Systematic Review
11. Classification Criteria
12. Epidemiology and Genetics
13. ReLiFiRa (Real Life Filgotinib in Rheumatoid Arthritis): Retrospective Study of Efficacy and Safety in Common Clinical Practice
14. Multidisciplinary management of patients with coexisting inflammatory bowel disease and spondyloarthritis: A Delphi consensus among Italian experts
15. Age at diagnosis influences the clinical phenotype, treatment strategies and outcomes in patients with giant cell arteritis: results from the observational GCAGE study on a large cohort of 1004 patients
16. Management of psoriatic arthritis: a consensus opinion by expert rheumatologists.
17. A whole blood test to measure SARS-CoV-2-specific response in COVID-19 patients
18. The Third Dose of BNT162b2 COVID-19 Vaccine Does Not “Boost” Disease Flares and Adverse Events in Patients with Rheumatoid Arthritis
19. Old and New Treatment for Behçet’s Disease
20. Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: Results from the GISEA register
21. Epidemiology of Psoriasis and Psoriatic Arthritis in Italy—a Systematic Review
22. Efficacy and safety profile of anti-interleukin-1 treatment in Behçet’s disease: a multicenter retrospective study
23. Interstitial lung disease in microscopic polyangiitis and granulomatosis with polyangiitis: demographic, clinical, serological and radiological features of an Italian cohort from the Italian Society for Rheumatology
24. Immune-Guided Therapy of COVID-19
25. Therapeutic Potential of Ixekizumab in the Treatment of Ankylosing Spondylitis: A Review on the Emerging Clinical Data
26. Tailored first-line biologic and targeted synthetic disease modifying anti-rheumatic drugs therapy in patients with rheumatoid arthritis: 2021 updated ITABIO statements
27. High rate of disease remission in moderate rheumatoid arthritis on etanercept therapy: data from GISEA, the Italian biologics register
28. COVID-19 epidemiology in rheumatic diseases in Tuscany: A case-control study
29. Quality of life and therapeutic management of axial spondyloarthritis patients in Italy: a 12-month prospective observational study
30. Mycobacterium tuberculosis Immune Response in Patients With Immune-Mediated Inflammatory Disease
31. Maintenance of improvement in spinal mobility, physical function and quality of life in patients with ankylosing spondylitis after 5 years in a clinical trial of adalimumab
32. Quality of life and unmet needs in patients with inflammatory arthropathies: results from the multicentre, observational RAPSODIA study
33. In-vitro evaluation of the immunomodulatory effects of Baricitinib: Implication for COVID-19 therapy
34. Old and New Treatment for Behçet’s Disease
35. Polymyalgia rheumatica and giant-cell arteritis
36. Fast spin echo-T2-weighted sequences with fat saturation in toe dactylitis of spondyloarthritis
37. Diagnosis and Treatment of Giant Cell Arteritis
38. Baricitinib Therapy in Covid-19 Pneumonia — An Unmet Need Fulfilled
39. JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortality
40. Comparison of two referral strategies for diagnosis of axial spondyloarthritis: the Recognising and Diagnosing Ankylosing Spondylitis Reliably (RADAR) study
41. Late onset undifferentiated spondyloarthritis presenting with polymyalgia rheumatica features: description of seven cases
42. Beneficial impact of Baricitinib in COVID-19 moderate pneumonia; multicentre study
43. CC chemokine receptor 5 polymorphism in Italian patients with Behçet’s disease
44. Polymyalgia rheumatica and giant-cell arteritis
45. Frequency of iridocyclitis in patients with early psoriatic arthritis: a prospective, follow up study
46. 2012 Provisional classification criteria for polymyalgia rheumatica: A European League Against Rheumatism/American College of Rheumatology collaborative initiative
47. Frequency of anemia of inflammation in patients with ankylosing spondylitis requiring anti-TNFα drugs and therapy-induced changes
48. Baricitinib therapy in COVID-19: A pilot study on safety and clinical impact
49. Systematic review on tuberculosis risk in patients with rheumatoid arthritis receiving inhibitors of Janus Kinases
50. Psoriatic arthritis: a systematic review
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.